Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease

Journal of the Neurological Sciences

Volumn 315, Issue 1-2, 2012, Pages 67-71

  Zhang, Wei ^a,b   Wang, Li Zhu ^c   Yu, Jin Tai ^b,d   Chi, Zhao Fu ^a   Tan, Lan ^b  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

^d OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Alzheimer's disease; Expression; Toll like receptor 2; Toll like receptor 4

Indexed keywords

BETA ACTIN; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; LATE ONSET ALZHEIMER DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84858001196     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.11.032     Document Type: Article

References (36)

1. Querfurth HW, LaFerla FM. Alzheimer's disease. N EngI J Med 2010;362:329-44.
2. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ. The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 2006;113:1685-95. (Pubitemid 44657664)
3. Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res 2008;39:1-16. (Pubitemid 350192021)
4. Yu JT, Song JH, Wang ND, Wu ZC, Zhang Q, Zhang N, et al. Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease. Neurobiol Aging 2010, doi:10.1016/j.neurobiolaging.2010.07.003.
5. Yu JT, Tan L, Song JH, Sun YP, Chen W, Miao D, et al. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res 2009;1253: 169-75.
6. Gordon S. Pattern recognition receptors: doubling up for the immune response. Cell 2002;111:927-30. (Pubitemid 36044685)
7. Kawai T, Akira S. TLR signaling. Semin Immunol 2007;19:24-32. (Pubitemid 46498752)
8. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi KI. Role of toll-like receptor signaling in Aβ uptake and clearance. Brain 2006;129:3006-19. (Pubitemid 44684521)
9. Udan ML, Ajit D, Crouse NR, Nichols MR. Toll-like receptors 2 and 4 mediate A beta(1-42) activation of the innate immune response in a human monocytic cellline. J Neurochem 2008;104:524-33. (Pubitemid 350293880)
10. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell Physiol Biochem 2007;20:947-56. (Pubitemid 350059737)
11. Yu JT, Sun YP, Ou JR, Cui WZ, Zhang W, Tan L. No association of toll-like receptor 2 polymorphisms with Alzheimer's disease in Han Chinese. Neurobiol Aging 2011;32:1924.e1-3.
12. Wang LZ, Tian Y, Yu JT, Chen W, Wu ZC, Zhang Q, et al. Association between late onset Alzheimer's disease and microsatellite polymorphisms in intron of the human toll-like receptor 2 gene. Neurosci Lett 2011;489:164-7.
13. Wang LZ, Yu JT, Miao D, Wu ZC, Zong Y, Wen CQ, et al. Genetic association of TLR4/11367 polymorphism with late-onset Alzheimer's disease in a Han Chinese population. Brain Res 2011;1381:202-7.
14. Minoretti P, Gazzaruso C, Vito DC, Emanuele E, Bianchi M, Coen ER, et al. Effect of the functional toll-like receptor Asp299Gly polymorphisms on susceptibility of late-onset Alzheimer's disease. Neurosci Lett 2006;391:147-9. (Pubitemid 41736189)
15. Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, Listì F, et al. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr Pharm Des 2008;14:2672-7.
16. Di Bona D, Candore G, Franceschi C, Licastro F, Colonna-Romano G, Cammà C, et al. Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev 2009;61:60-8.
17. Di Bona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C, et al. Association between the interleukin-1 beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res Rev 2008;59:155-63.
18. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune response through multiple TLRs. J Immunol 2004;173:3916-24. (Pubitemid 39280755)
19. Tang SC, Lathia JD, Selvaraj PK, Jo DG, Mughal MR, Cheng A, et al. Toll-like recepyor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp Neurol 2008;213: 114-21.
20. Letiembre M, Liu Y, Walter S, Hao W, Pfander T, Wrede A, et al. Sceening of innate immune receptors in neurodegenerative disease: a similar pattern. Neurobiol Aging 2009;30:759-68.
21. Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM. Plasma clusterin and the risk of Alzheimer disease. JAMA 2011;305:1322-6.
22. Uberti D, Cenini G, Bonini SA, Barcikowska M, Styczynska M, Szybinska A, et al. Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients. Neurodegener Dis 2010;7:143-7.
23. McKhann G, Drachman D, Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44. (Pubitemid 14076461)
24. Candore G, Balistreri CR, Grimaldi MP, Listì F, Vasto S, Chiappelli M, et al. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach. Mech Ageing Dev 2007;128:67-75. (Pubitemid 46073062)
25. Yu JT, Mou SM, Wang LZ, Mao CX, Tan L. Toll-like receptor 2-196 to -174 del polymorphism influences the susceptibility of Han Chinese people to Alzheimer's disease. J Neuroinflammation 2011;8:136.
26. Duan ZX, Gu W, Zhang LY, Du DY, Hu P, Huang J, et al. Clinical relevance of the TLR4 11367 polymorphism in patients with major trauma. Arch Surg 2009;144: 1144-8.
27. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006;117:979-87.
28. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801. (Pubitemid 43261452)
29. Bowmann CC, Rasley A, Tranguch SL, Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003;43:281-91. (Pubitemid 37047684)
30. Iwamura C, Nakayama T. Toll-like receptors in the respiratory system: their roles in inflammation. Curr Allergy Asthma Rep 2008;8:7-13. (Pubitemid 351459687)
31. Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, et al. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 2004;199: 81-90. (Pubitemid 38076480)
32. Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation 2008;5:23.
33. Subramaniam K, Chen K, Joseph K, Raymond JR, Tholanikunnel BG. The 3′untranslated region of the beta2-adrenergic receptor mRNA regulates receptor synthesis. J Biol Chem 2004;279:27108-15. (Pubitemid 38812547)
34. Izquierdo JM, Cuezva JM. Epigenetic regulation of the binding activity of translation inhibitory proteins that bind the 3′ untranslated region of beta-F1-ATPase mRNA by adenine nucleotides and the redox state. Arch Biochem Biophys 2005;433:481-6. (Pubitemid 39592803)
35. Pancer Z, Cooper MD. The evolution of adaptive immunity. Annu Rev Immunol 2006;24:497-518.
36. Miyake K. Innate immune sensing of pathogens and danger signals by cell surface toll-like receptors. Semin Immunol 2007;19:3-10. (Pubitemid 46498750)